Strategic Acquisition Potential sales opportunity with Hims & Hers Health post-acquisition: leverage YourBio Health’s remote capillary blood collection technology to broaden Hims & Hers’ telehealth and at-home testing capabilities, offering a seamless patient experience and potentially integrated diagnostics.

Board & Leadership New leadership and board appointments (CEO from Flagship Pioneering; two new directors) signal a growth and commercialization push, creating chances to engage at the strategic partnership level, expand visibility with enterprise accounts, and explore co-development or pilot programs.

Clinical Convenience Market opportunity with healthcare providers seeking patient comfort and throughput: promote TAP as a patient-friendly alternative to traditional venipuncture for clinics and hospital networks aiming to reduce appointment time, improve flow, and lower no-show rates.

Remote Diagnostics Target integrations with remote or at-home testing platforms and telemedicine services: position TAP as a complementary device for remote blood sampling, enabling end-to-end workflows for wearables, labs, and digital health ecosystems.

Strategic Partnerships Explore collaborations with diagnostics laboratories, medical device distributors, and solutions providers (e.g., RecoveryTrek biomarker testing partner) to scale adoption, manufacturing, and kit fulfillment across regions, including UK and other markets with existing supply relationships.